Video walkthrough
Prescription Review worked through on the exam interface, with the BNF open, in 9 min.
At a glance
| Question style | Tick one or two prescriptions on a medication list |
|---|---|
| What you do | Tick the responsible prescription(s) on a drug chart |
| Primary skill | Finding the culprit drug in a realistic chart |
| BNF use | Interactions, side-effects, contra-indications, renal impairment |
| On PassthePSA | The same chart with a tick column per question part. 238 questions in this section, rated easy to hard. |
What this section is really testing
- Matching a new symptom, a new result or a new risk to the prescription that best explains it, using timing as the main clue.
- Recognising interactions on a list: the pair that together cause the problem, or the newly started drug that raised the level of an old one.
- Spotting the contraindicated prescription: a drug that should not be there given the patient's disease, allergy or organ function.
- Reading a chart under time pressure without checking every monograph, because the story tells you where to look.
A repeatable approach
- Read the problem firstBefore the chart: what has gone wrong, and when did it start?
- Find what changedA drug started or increased just before the problem is the prime suspect. Dates on the chart matter.
- Ask the timing questionDoes the interval fit? A rash on day 8 of a penicillin fits; a rash two years into amlodipine does not.
- Check the pairIf two drugs could act together, open one monograph's interactions and look for the other.
- Confirm, then tickOne lookup to confirm the mechanism. Then tick the prescription, not the drug that treats the problem.
Using the BNF for this section
The exam is open book, and the time is short. Know which heading answers which question before you open the monograph.
| If you need to know | Look under |
|---|---|
| Could this drug cause that symptom? | Side-effects, and the frequency band it sits in |
| Do these two clash? | Interactions, from either monograph |
| Should this drug be on the chart at all? | Contra-indications and cautions |
| The kidneys are struggling | Renal impairment |
| Is the dose too high for this patient? | Indications and dose |
The general technique, with timed lookups, is in the BNF guide.
Scanning a chart without reading every monograph
Six drugs make fifteen possible pairs, and two minutes will not cover them. Read the chart with six questions, in this order, and stop as soon as one lights up.
Common traps
| Trap | Why it costs marks |
|---|---|
| The drug that treats it | The question asks what caused the problem. The antiemetic on the chart is not the reason for the nausea. |
| Plausible but the timing is wrong | Many drugs could cause the symptom in general. Only one fits the dates on the chart. |
| Two answers when one is asked | Read whether the item wants one prescription or two. Extra ticks lose marks. |
| Missing the pair | The second drug is innocent alone; together with the first it is the answer. |
| Ignoring organ function | A normal dose becomes an overdose when the creatinine has doubled since it was started. |
Areas worth being comfortable with
Not predictions. These are the broad clinical areas this section draws on, taken from the shape of the exam and the BNF; being fluent in them makes the lookup fast.
- Interactions that raise drug levels: macrolides, azoles, amiodarone, grapefruit
- Serotonin syndrome and other additive toxicities
- Bleeding risk: anticoagulants with antiplatelets and NSAIDs
- Hyperkalaemia and hyponatraemia from drug combinations
- Nephrotoxic combinations and dosing in renal impairment
- Anticholinergic burden in older patients
- QT prolongation
- Hypoglycaemia in treated diabetes
- Falls, sedation and postural hypotension
- Allergy and cross-reactivity
What this section covers in the bank
Topics with the most prescription review questions at the last build, counted by the app's topic search; each link opens that topic in the app.
- Infection and antibiotics · 56
- Diabetes · 49
- Depression, psychosis and mental health · 41
- Stomach, bowel and nausea · 34
- Atrial fibrillation and anticoagulants · 33
- Pain and opioids · 32
- Kidney disease and renal dosing · 23
- Steroids and adrenal · 22
Worked examples
These are real questions from the PassthePSA bank, free to every visitor. Work each one with the BNF open before you show the answer; at exam pace a 4-mark item has 2 min 24 s.
An 84-year-old with two weeks of confusion, a dry mouth and constipation
Case
An 84-year-old woman is brought to the frailty assessment unit by her daughter, who says her mother has been muddled for about 2 weeks — losing the thread of conversations, drowsy in the afternoons, and constantly sipping water because her mouth is dry. She has opened her bowels twice in the past week, passing hard stools despite her usual laxative. Three weeks ago her general practitioner started a tablet for nausea, which has settled. Her bladder symptoms of urgency have been treated with the same tablet for 4 years. Her current prescriptions are shown.
PMH: Urge urinary incontinence; hypertension; hypercholesterolaemia; hypothyroidism; chronic constipation; osteoarthritis of the knees.
DH: As charted; no over-the-counter or herbal preparations; no known drug allergies.
SH: Lives alone with daily family visits; lifelong non-smoker; no alcohol.
On examination: Temperature 36.9°C, HR 96/min regular, BP 142/84 mmHg, RR 16/min, O2 sat 96% breathing air. Drowsy but rousable; inattentive, with an abbreviated mental test score of 6/10 against 9/10 documented at a clinic visit 4 months ago. Oral mucosa dry. Abdomen soft with palpable stool in the left iliac fossa; the bladder is palpable above the pubis after she has passed urine. No focal neurology.
Investigations: Na 139 mmol/L (133–146) K 4.2 mmol/L (3.5–5.3) Urea 6.0 mmol/L (2.5–7.8) Cr 74 µmol/L (45–90) eGFR 69 mL/min/1.73 m² (>60) Glucose 5.4 mmol/L (4.0–7.8) TSH 2.1 mU/L (0.3–4.2) CRP 4 mg/L (<5) Urine dipstick: negative for nitrites, leucocytes and blood
Question
Question A: Select the ONE prescription most likely to have precipitated her confusion. (mark it with a tick in column A)
Question B: Select the ONE OTHER prescription contributing to her anticholinergic burden.
(mark it with a tick in column B)
Current prescriptions
- amlodipine
- atorvastatin
- cyclizine
- levothyroxine
- paracetamol
- senna
- tolterodine
Tick one prescription in each column: A, B.
Show the answer and markingHide the answer
cyclizine
Marks2
Explanation2 marks for ticking the cyclizine and nothing else. Assemble the picture first: two weeks of fluctuating confusion and drowsiness, a dry mouth she waters all day, hard infrequent stools, a resting rate of 96/min and a bladder still palpable after voiding — the peripheral and central signature of antimuscarinic excess. Then read the chart against time. The only prescription started inside the window is cyclizine, added 3 weeks ago for nausea. Its Summary of Product Characteristics (ADVANZ Pharma, revised February 2024) treats it 'as with other anticholinergic agents', warning of precipitated glaucoma and urinary retention, and lists 'Dryness of the mouth, nose and throat', 'Urinary retention' and disorientation among its effects — in a first-generation antihistamine this is expected pharmacology, and in an 84-year-old already on a bladder antimuscarinic it is predictable harm. The infective and metabolic mimics are all closed on paper: apyrexial, CRP 4, glucose, sodium and renal function normal, dipstick negative, TSH 2.1. The habit to take away: every new drug in a confused elderly patient is guilty until proved otherwise, and sedating antihistamines head the list.
tolterodine
Marks2
Explanation2 marks for ticking the tolterodine and nothing else. Anticholinergic burden is cumulative, and the question asks for the drug that set the baseline. Tolterodine is a bladder antimuscarinic: dry mouth is its commonest effect (35% against 10% with placebo in its SmPC), and confusion, hallucinations, disorientation and memory impairment are all reported reactions. Its Summary of Product Characteristics (Detrusitol, Viatris, revised January 2026) states the additive rule in terms: 'Concomitant medication with other drugs that possess antimuscarinic properties may result in more pronounced therapeutic effect and side-effects.' Four years of trouble-free use does not acquit it — it means she was compensating until a second antimuscarinic arrived. No other row competes: amlodipine, atorvastatin, paracetamol and senna have no antimuscarinic pharmacology in their SmPCs, and levothyroxine is closed by the in-range TSH. The management follows from the two ticks: stop the cyclizine, and review whether the tolterodine is still earning its place — in the frail elderly it usually is not.
© 2026 PassthePSA · Question REV-83 · Free sample for personal study. Copying, republishing or AI training use is not permitted (terms).
A 74-year-old with recurrent hypoglycaemia in general practice
Case
A 74-year-old man is reviewed urgently in general practice after his wife found him pale, sweating and confused in the garden mid-morning; paramedics recorded a capillary glucose of 2.6 mmol/L and he recovered fully with oral glucose. A near-identical episode happened 3 weeks ago. On neither occasion did he notice palpitations, tremor or hunger beforehand. He has had type 2 diabetes for 12 years. Two months ago his glimepiride was increased after a raised HbA1c, and 6 weeks ago propranolol was restarted for the return of his long-standing migraine. He eats breakfast at seven and takes his morning tablets with it. His current prescriptions are shown.
PMH: Type 2 diabetes mellitus; hypertension; migraine; hypercholesterolaemia; gastro-oesophageal reflux disease; osteoarthritis of the hips.
DH: As charted; no over-the-counter or herbal preparations; no known drug allergies.
SH: Retired postman; lives with his wife; drinks 4 units of alcohol a week; ex-smoker.
On examination: Temperature 36.7°C, HR 58/min regular, BP 134/78 mmHg, RR 14/min, O2 sat 97% breathing air. Weight 71 kg. Alert and fully orientated at review. Cardiovascular, respiratory and abdominal examinations normal. No focal neurology.
Investigations: Capillary glucose during this morning's episode 2.6 mmol/L (4.0–7.8) HbA1c 44 mmol/mol (target 53), and 58 mmol/mol 3 months ago Na 140 mmol/L (133–146) K 4.4 mmol/L (3.5–5.3) Urea 6.8 mmol/L (2.5–7.8) Cr 88 µmol/L (60–120) eGFR 79 mL/min/1.73 m² (>60) ALT 22 U/L (<40)
Question
Question A: Select the ONE prescription most likely to be causing his hypoglycaemic episodes. (mark it with a tick in column A)
Question B: Select the ONE prescription most likely to be masking the warning symptoms of the episodes.
(mark it with a tick in column B)
Current prescriptions
- amlodipine
- atorvastatin
- glimepiride
- lansoprazole
- metformin
- paracetamol
- propranolol
Tick one prescription in each column: A, B.
Show the answer and markingHide the answer
glimepiride
Marks2
Explanation2 marks for ticking the glimepiride and nothing else. Only one drug on this chart makes insulin: glimepiride, a sulfonylurea that stimulates secretion regardless of the prevailing glucose, which is why its SmPC (Brown & Burk, revised December 2020) builds its central warnings around hypoglycaemia. The chart tells the story in numbers: the dose was doubled to 4 mg two months ago, the HbA1c has fallen from 58 to 44 mmol/mol — well through the target of 53 — and two mid-morning collapses at a capillary glucose of 2.6 mmol/L have followed the morning dose. That is over-treatment in a 74-year-old, in whom the honest correction is a dose reduction, not just a snack. Do not tick the metformin: its own SmPC closes it in one sentence — 'It does not stimulate insulin secretion and therefore does not cause hypoglycaemia.' The remaining rows have no glycaemic pharmacology at all, and the printed eGFR of 79 removes renal accumulation as a competing mechanism. The rule that transfers: when a diabetic chart produces a low glucose, find the secretagogue (or the insulin) first, and ask what changed and when.
propranolol
Marks2
Explanation2 marks for ticking the propranolol and nothing else. The clue is what is missing: on neither occasion did he feel palpitations, tremor or hunger before the collapse. Those early warnings are adrenergic — driven by the catecholamine surge of counter-regulation — and a non-selective beta-blocker sits directly on top of them. Propranolol's SmPC (Amarox, revised April 2026) says so twice: it 'may block/modify the signs and symptoms of the hypoglycaemia (especially tachycardia)' and it 'modifies the tachycardia of hypoglycaemia', with the explicit instruction that 'Caution must be exercised in the concurrent use of propranolol and hypoglycaemic therapy in diabetic patients.' The glimepiride SmPC states the same interaction from the other side: under beta-blockers 'the signs of adrenergic counter regulation to hypoglycaemia may be reduced or absent.' Restarted 6 weeks ago for migraine, propranolol is the only sympatholytic row on the chart — nothing else has adrenergic pharmacology to lose. The practical lesson: in a patient on a sulfonylurea or insulin who needs a beta-blocker, a cardioselective agent is the safer habit, and any beta-blocker demands a warning that hypoglycaemia may now announce itself only as sweating or confusion.
This example on its own page, with the method and checklist →
© 2026 PassthePSA · Question REV-84 · Free sample for personal study. Copying, republishing or AI training use is not permitted (terms).
A 71-year-old with six months of ankle swelling at a medication review
Case
A 71-year-old woman attends her general practice for her annual medication review. Her ankles have been swollen for the past six months; they were recorded as normal at every previous review, including her last, nine months ago. She has not been breathless. She takes everything as prescribed except the naproxen, taken only during a flare and not taken for 5 weeks.
PMH: Type 2 diabetes of ten years, with painful peripheral neuropathy; hypertension; osteoarthritis of the right shoulder; primary hypothyroidism; vitamin D insufficiency.
DH: Her repeat prescriptions are listed (right); no known drug allergies. The amlodipine and the atorvastatin are unchanged for seven years, the levothyroxine and the metformin older still, the colecalciferol five years. The naproxen, for her shoulder, and the lansoprazole, for gastric protection while she takes it, were started together on the same day, a little over nine months ago — a week before the review at which her ankles were normal. The pregabalin was started for the neuropathy three weeks before the ankles swelled. The furosemide was added six days after the swelling appeared, with 'ankle swelling' written as its indication.
SH: Retired; lives with her husband.
On examination: HR 74/min, BP 132/78 mmHg. Weight 68 kg, unchanged from the day the furosemide was started. Painless pitting oedema to mid-shin, equal on the two sides; no varicose veins. Jugular venous pressure not raised; heart sounds normal; chest clear. No hepatomegaly and no ascites. Reduced pinprick sensation to mid-calf on both sides.
Investigations: Hb 131 g/L (120–150) MCV 89 fL (80–100) K⁺ 3.6 mmol/L (3.5–5.3) eGFR 75 mL/min/1.73 m² (>60) Albumin 41 g/L (35–50) TSH 2.4 mU/L (0.4–4.0) Vitamin B12 421 ng/L (180–900) Urine dipstick: negative for protein and blood
Question
Question A: Select the ONE prescription that has caused the problem for which another medicine on this list was later started. (mark it with a tick in column A)
Question B: Select the ONE prescription that was started only to treat an adverse effect of another medicine on this list.
(mark it with a tick in column B)
Repeat prescriptions
- amlodipine
- atorvastatin
- colecalciferol
- furosemide
- lansoprazole
- levothyroxine sodium
- metformin hydrochloride
- naproxen
- pregabalin
Tick one prescription in each column: A, B.
Show the answer and markingHide the answer
pregabalin
Marks2
Explanation2 marks for the correct tick. Do this with a calendar rather than with a list of side effects. The symptom is bilateral pitting ankle oedema. It was absent at a review nine months ago and at every review before that, and it appeared six months ago. Now read the start dates: amlodipine seven years ago, atorvastatin seven years ago, colecalciferol five years ago, levothyroxine fifteen years ago, metformin ten years ago, naproxen and lansoprazole a little over nine months ago — and pregabalin three weeks before the ankles swelled. Only one thing on the page is new enough to be the cause.
That matters because the pharmacology points the other way. Amlodipine is the drug everybody associates with ankle oedema, and rightly: its Summary of Product Characteristics lists oedema as very common and ankle swelling as common, which is a stronger association than pregabalin's 'common'. But amlodipine oedema is dose-related and appears within weeks of starting or of an increase, and this dose has not changed in seven years, during which her ankles were fine and stayed fine for seven years. A very common adverse effect of a drug she has tolerated for seven years is less likely than a common adverse effect of a drug she started three weeks before the symptom. The strength of the association tells you what to think of first; the dates tell you what actually happened.
Rule out the things that are not drugs before you commit, because 'drug-induced' is a diagnosis of exclusion in a 71-year-old with swollen ankles: the jugular venous pressure is not raised, the heart sounds are normal, the chest is clear, the albumin is 41 g/L, the urine has no protein, the estimated glomerular filtration rate is 75 mL/min/1.73 m², the thyroid-stimulating hormone is normal and there is no hepatomegaly, no ascites and no varicose veins. Do not tick the naproxen: she has taken none for 5 weeks and her ankles were normal for about three months after it was started. The action is to review the pregabalin — reduce it or change the neuropathic agent, and reassess the ankles in a month.
furosemide
Marks2
Explanation2 marks for the correct tick. The furosemide was started six days after the swelling appeared and four weeks after the drug that caused it, and its indication is written on the list as 'ankle swelling' — a symptom, not a diagnosis. That is what a cascade prescription looks like: an adverse effect is read as a new problem, and a second medicine is added for it.
Two details tell you it is not working and was never going to. Her weight is 68 kg today and was 68 kg the day it was started, and the ankles are unchanged. Drug-induced peripheral oedema is a capillary and vasodilatory phenomenon at the ankles rather than an excess of total body water, so a loop diuretic has nothing to remove; it simply takes fluid from a normovolaemic woman. And it is not free. Her potassium is 3.6 mmol/L, at the bottom of the range, on a diuretic that lowers it; a loop diuretic in a 71-year-old also brings hypovolaemia, acute kidney injury, urinary urgency and night-time falls. Six months of that has bought nothing.
The row that catches people out is the lansoprazole. It was started because of another medicine — the indication says so — and a quick reader will tick it. It is a COMPANION prescription, not a cascade: it prevents an adverse effect that has not happened, on the instruction of a guideline, in a patient whose age puts her at risk, and it is licensed for precisely that ('Prophylaxis of NSAID-associated gastric ulcers and duodenal ulcers in patients at risk', 15 mg once daily). Look at the dates as well as the words: the lansoprazole and the naproxen were both started on the same day, a little over nine months ago, because they were written together. A cascade drug always comes later, because it is a response to something that happened after the first drug was started. Getting this the wrong way round has a cost in both directions — leaving an at-risk patient on a non-steroidal anti-inflammatory drug without gastroprotection is a defect, and stopping the gastroprotection because it looked like a cascade would create one.
The pregabalin cannot be ticked here, and it is worth knowing why properly rather than by reflex. It would be the right answer if something on this list had caused the neuropathy it treats, and there is a row with a real claim: metformin, taken for ten years, causes vitamin B12 malabsorption, and B12 deficiency causes a peripheral neuropathy. That would be a complete second cascade — metformin, deficiency, neuropathy, pregabalin — and it is the kind of thing this section exists to teach you to look for. Look, then: vitamin B12 421 ng/L (180–900), haemoglobin 131 g/L, mean cell volume 89 fL. All normal, so there is no deficiency and no cascade. What caused her neuropathy is her diabetes, and a disease is not an adverse effect. Do the two things in order — stop the furosemide, and review the drug that made the ankles swell — and check her ankles, her weight, her renal function and her potassium in a month.
This example on its own page, with the method and checklist →
© 2026 PassthePSA · Question REV-80 · Free sample for personal study. Copying, republishing or AI training use is not permitted (terms).
Before you submit
- Have I found the drug that fits the timing, not just one that could cause the problem?
- Did I tick the cause, not the treatment?
- Does the question want one prescription or two?
- If it is an interaction, have I named both halves?
- Have I checked organ function against the dose?
Practise this section
Practise Prescription Review on its own, or meet it in exam proportions inside a full mock paper. The practice questions are written to reflect the PSA's format and marking closely; PassthePSA is independent of the assessment provider.
Practise Prescription Review questions 238 questions, each with a full explanation
Section sizes and marks follow the published PSA blueprint. The BNF headings named here are the current online BNF's. Check any dose or threshold against the BNF before you rely on it; this page teaches the method, the BNF holds the numbers.